[Rubella vaccination].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D002648:Child; D000013:Congenital Abnormalities / Q000453:epidemiology / Q000209:etiology; D003270:Contraceptive Agents / Q000008:administration & dosage; D004622:Embryo, Mammalian / Q000276:immunology; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D005333:Fetus / Q000276:immunology; D005860:Germany, West; D006801:Humans; D007115:Immunization Schedule; D007136:Immunoglobulins / Q000032:analysis; D007231:Infant, Newborn; D007592:Joint Diseases / Q000209:etiology; D008423:Maternal Age; D008457:Measles / Q000150:complications / Q000175:diagnosis; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D012409:Rubella / Q000517:prevention & control*; D012411:Rubella Vaccine; D012698:Serologic Tests; D014765:Viral Vaccines / Q000009:adverse effects*; D005719:gamma-Globulins / Q000627:therapeutic use
D000906:Antibodies; D003270:Contraceptive Agents; D007136:Immunoglobulins; D012411:Rubella Vaccine; D014765:Viral Vaccines; D005719:gamma-Globulins
Probleme der Rotelnschutzimpfung.